KathrynAnnGoldMD

Oncology • La Jolla, CA

Hematologic Oncology

Associate Professor, University of California San Diego

Join to view full profile

Dr. Gold is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gold's full profile

Already have an account?

Office
3855 Health Sciences Dr # 987
La Jolla, CA 92093
Phone+1 858-822-5182

Fax+1 858-822-6186
Is this information wrong?

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
University of Pennsylvania Health SystemResidency, Internal Medicine, 2005 - 2008
Washington University in St. Louis School of MedicineClass of 2005

Certifications & Licensure

CA State Medical License 2015 - 2025
TX State Medical License 2008 - 2024
PA State Medical License 2005 - 2008
American Board of Internal Medicine Medical Oncology

Clinical Trials

Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin Start of enrollment: 2011 Feb 01
Terminated
Phase 2
Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2018 Jun 06
Active, not recruiting
Phase 1

Publications & Presentations

PubMed

4 citations
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
William N William Jr, Jianjun Zhang, Xin Zhao, Edwin R Parra, Naohiro Uraoka, Heather Y Lin, S Andrew Peng, Adel K El-Naggar, Jaime Rodriguez-Canales, Jaejoon Song, An...> ;Cancer. 2023 Mar 1
4 citations
A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Michael J Dennis, Assuntina G Sacco, Yuchen Qi, Julie Bykowski, Emily Pittman, Ruifeng Chen, Karen Messer, Ezra E W Cohen, Kathryn A Gold> ;Oral Oncology. 2022 Dec 1
8 citations
Clinicopathologic and molecular characteristics of-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy.
Li Yu, Lyudmila Bazhenova, Kathryn Gold, Lisa Tran, Van Hilburn, Peter Vu, Sandip Pravin Patel> ;Translational Lung Cancer Research. 2022 Mar 1
17 citations
Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic.
Jade Zifei Zhou, Shelly Kane, Celia Ramsey, Melody Akhondzadeh, Ananya Banerjee, Rebecca Shatsky, Kathryn Ann Gold> ;JAMA Network Open. 2022 Feb 1
A framework and road map for rapid start-up and completion of a COVID-19 vaccine trial: A single clinical trial site experience.
Carlos Rojas, Stephen A Spector, Bernadette Cale, Megan Loughran, Leander Lazaro, Eric Mah, Gary S Firestein, Kathryn A Gold, Mark Wallace> ;Journal of Clinical and Translational Science. 2022 Jan 1
122 citations
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, Collin Blakely, Anne Chiang, Thomas A D'Amico, Christopher D'Avella, Afshin Dowlati, Robert J Downey, Martin Edelma...> ;Journal of the National Comprehensive Cancer Network. 2021 Dec 1
80 citations
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer.
Pasi A. Jänne, Christina S. Baik, Wu Chou Su, Melissa Lynne Johnson, Hidetoshi Hayashi, Makoto Nishio, Dong Wan Kim, Marianna Koczywas, Kathryn A. Gold, Conor E. Steue...> ;Cancer Discovery. 2021 Sep 21
2 citations
A Hospital-Wide Intervention to Improve Compliance With TNM Cancer Staging Documentation.
Jason Han Lee, Tariq Mohamed, Celia Ramsey, Jihoon Kim, Shelly Kane, Kathryn A. Gold, Farhoud Faraji, Joseph A. Califano> ;Journal of the National Comprehensive Cancer Network. 2021 Aug 27
Biotin-induced thyroid stimulating hormone aberrations in the setting of immunotherapy:
Forrest N Ridgway, Kathryn A. Gold, Linda Barnachea> ;Journal of Oncology Pharmacy Practice. 2021 May 21
100 citations
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, pha...
Assuntina G. Sacco, Ruifeng Chen, Francis P. Worden, Deborah J.L. Wong, Douglas Adkins, Paul L. Swiecicki, Wanxing Chai-Ho, Peter Oppelt, Debanjali Ghosh, Julie Bykows...> ;The Lancet. Oncology. 2021 Jun 1
Scirrhous carcinoma: A previously undescribed tumor of the oral cavity.
Jacquelyn K. DeVries, Andrey Finegersh, Kathryn A. Gold, Andrew B. Sharabi, Jingjing Hu, Ryan K. Orosco> ;Clinical Case Reports. 2021 May 4
20 citations
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer.
Jean Bourhis, Alexander Stein, Jan de Boer, Marc Van den Eynde, Kathryn A. Gold, Sebastian Stintzing, Jürgen C. Becker, Michael Moran, Andreas Schroeder, Gregory Penno...> ;Cancer Treatment Reviews. 2021 Mar 2
10 citations
Planning for post-pandemic cancer care delivery: Recovery or opportunity for redesign?
Pelin Cinar, Richard J. Bold, Bryn A. Bosslet, Daniela A. Bota, Debra Burgess, Helen K. Chew, Joshua G. Cohen, Emad Elquza, Kathryn A. Gold, Emi Kamiya, Beth Y. Karlan...> ;CA. 2021 Jan 1
13 citations
Rapid onset type 1 diabetes with anti-PD-1 directed therapy.
Karen Yun, Gregory A. Daniels, Kathryn A. Gold, Karen C. McCowen, Sandip Pravin Patel> ;Oncotarget. 2020 Jul 14
68 citations
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
Steven Francis Powell, Kathryn A. Gold, Mark M. Gitau, Christopher Joseph Sumey, Michele Lohr, Steven McGraw, Ryan Kenneth Nowak, Ashley Wayne Jensen, Miran J. Blancha...> ;Journal of Clinical Oncology. 2020 Jun 1
23 citations
Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations
Siddhartha Devarakonda, Sumithra Sankararaman, Brett H. Herzog, Kathryn A. Gold, Saiama N. Waqar, Jeffrey P. Ward, Victoria M. Raymond, Richard B. Lanman, Aadel A. Cha...> ;Clinical Cancer Research. 2019 Oct 15
77 citations
Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics
Sayuri Miyauchi, Sangwoo S. Kim, John Pang, Kathryn A. Gold, J. Silvio Gutkind, Joseph A. Califano, Loren K. Mell, Ezra E.W. Cohen, Andrew B. Sharabi> ;Clinical Cancer Research. 2019 Jul 15
15 citations
Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced h...
Robert I. Haddad, Erminia Massarelli, J. Jack Lee, H. Lin, Katherine A. Hutcheson, Jeff Lewis, Adam S. Garden, George R. Blumenschein, William N. William, Rebecca Phar...> ;Annals of Oncology. 2019 Mar 1
2 citations
Immunotherapeutic Approaches to the Management of Head and Neck Cancer.
Xinyu Nan, Kathryn A. Gold, Ezra E.W. Cohen> ;Oncology. 2018 Dec 17
93 citations
Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials
D. Ross Camidge, Dong Wan Kim, Marcello Tiseo, Corey J. Langer, Myung-Ju Ahn, Alice T. Shaw, Rudolf M. Huber, Maximilian Hochmair, Dae Ho Lee, Lyudmila Bazhenova, Kath...> ;Journal of Clinical Oncology. 2018 May 16
78 citations
Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial
Kathryn A. Gold, Merrill S. Kies, William N. William, Faye M. Johnson, J. Jack Lee, Bonnie S. Glisson> ;Cancer. 2018 May 15
40 citations
Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models.
Denise L. Crossland, Warren Denning, Sonny Ang, Simon Olivares, Tiejuan Mi, Kirsten Switzer, Harjeet Singh, Helen Huls, Kathryn A. Gold, Bonnie S. Glisson, Laurence J....> ;Oncogene. 2018 Apr 6
24 citations
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer
Tina Cascone, Kathryn A. Gold, Stephen G. Swisher, Diane D. Liu, Frank V. Fossella, Boris Sepesi, Apar Pataer, Annikka Weissferdt, Neda Kalhor, Ara A. Vaporciyan, Wayn...> ;The Annals of Thoracic Surgery. 2017 Dec 6
19 citations
Modulation of Biomarker Expression by Osimertinib: Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I Trial.
Kenneth S. Thress, Vivien Jacobs, Helen K. Angell, James Chih-Hsin Yang, Lecia V. Sequist, Fiona H Blackhall, Wu Chou Su, Martin Schuler, Jürgen Wolf, Kathryn A. Gold,...> ;Journal of Thoracic Oncology. 2017 Oct 1
54 citations
The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer
Boris Sepesi, Kathryn A. Gold, Arlene M. Correa, John V. Heymach, Ara A. Vaporciyan, Jason Roszik, Ethan Dmitrovsky, Xi Liu> ;Journal of Thoracic Oncology. 2017 Aug 1
Join now to see all

Press Mentions

COVID-19 Pandemic Is Driving up Rate of Late-Stage Cancer Diagnoses, UCSD Researchers SayFebruary 17th, 2022
Increase in Late-Stage Cancer Diagnoses After PandemicFebruary 15th, 2022
COVID Pandemic Driving up Late-Stage Cancer Rates, UCSD FindsFebruary 15th, 2022